How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Items 601–700 of 1,000
Chen, M., Surbhi, S., & Bailey, J. E. (2021) · American Journal of Health Promotion · doi:10.1177/08901171211024426 · Cited by 8
Solé, T., Januel, L., Denneval, A., Williet, N., Breton, C., Blanc, P., & Ollier, É. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.02.003 · Cited by 8
Remission with an Intervention
Hanipah, Z. N., Rubino, F., & Schauer, P. R. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.09.002 · Cited by 10
Self-citationDoes length of common limb influence remission of diabetes? Short-term results
Gupta, R. N., Chamany, T., & Makam, R. (2015) · Journal of Minimal Access Surgery · doi:10.4103/0972-9941.152104 · Cited by 8
“The National Institutes of Health guidelines were used as the criteria for diabetes remission, i.e. 3-5] Statistical Analysis Descriptive and inferential statistical analyses have been carried out in the present study.”
Goel, R., Amin, P. R., Goel, M., & Marik, S. (2011) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-011-0021-7 · Cited by 8
Fan, J., Xu, J. H., Wang, J., Wang, G. Z., Zhang, Y. Q., & Liu, X. (2014) · Obesity Surgery · doi:10.1007/s11695-013-1173-y · Cited by 8
“6 mmol/L) and HbA1c<6 % for at least 1 year without active pharmacologic therapy [10].”
BackgroundMetabolic response 4 years after gastric bypass in a complete cohort with type 2 diabetes mellitus
Leon, B. G. C., Puzziferri, N., ADAMS-HUET, B. A., Jabbour, I. I., & Lingvay, I. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.022 · Cited by 8
Papadia, F. S., Carlini, F., Rubartelli, A., Battistini, M., Cordera, R., Adami, G. F., & Camerini, G. B. (2022) · Obesity Surgery · doi:10.1007/s11695-021-05870-4 · Cited by 8
“Following the operation, T2DM was regarded as remitted when serum FBG concentration was steadily lower than 125 mg/ml at free diet and without taking any anti-diabetic medication [26].”
MethodFoschi, D., Sorrentino, L., Tubazio, I., Vecchio, C., Vago, T., Bevilacqua, M. T., Rizzi, A., & Corsi, F. (2018) · Surgical Endoscopy · doi:10.1007/s00464-018-6443-2 · Cited by 8
Castro, F. M. P.-G., García, J. G. O., Núñez, M. A. G., Bray, B. F. G., Llanos, J. P. S., Arce, M. E. M., & Abizanda, J. E. P. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.08.007 · Cited by 12
Impact of metabolic surgery on health-related quality of life and quality of alimentation
Seki, Y., Pantanakul, S., Kasama, K., Kikkawa, E., Nakazato, T., & Porciuncula, J. P. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.022 · Cited by 8
From Entero-Endocrine Cell Biology to Surgical Interventional Therapies for Type 2 Diabetes
Guimarães, M., Pereira, S. S., & Monteiro, M. P. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_480 · Cited by 9
Review of the potential value of treatment targets in obesity management
Almohaileb, F. I., & le Roux, C. W. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2516522 · Cited by 8
“This observation led to using surgery to induce T2D remission, though there was no consensus on defining remission at the time [11].”
Xu, S., Shao, J., Zhang, Y., Si, W., Mao, Y., Du, S., & Zhang, F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327210 · Cited by 7
Evidências e dúvidas sobre o tratamento cirúrgico do diabetes tipo 2
Ceneviva, R., Viegas-Silva, M. M., dos Santos, J. S., Salgado, W., & Júnior, O. C. E. S. (2011) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v44i4p402-413 · Cited by 9
Davoudi, Z., Dehkordi, S. R., Nikpour, S., Shafiee, M., Mohammadian, A., & Farsi, Y. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.03.001 · Cited by 7
Hart, K. J., Kubilius, A., & Clark, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294344 · Cited by 8
“Studies were restricted to 2009 onwards when the first preliminary discussion on remission descriptors and criteria, was published [15].”
BackgroundBMI Guidelines for Bariatric Surgery in Diabetes: How Low Can We Go?
Ryan, D. H. (2012) · Diabetes Care · doi:10.2337/dc12-0729 · Cited by 7
“The appreciation that bariatric surgery might yield remission of diabetes stimulated the American Diabetes Association (ADA) to convene a consensus committee to define the terms “partial remission,” “complete remission,” and “durable remission” (4).”
BackgroundVaurs, C., Brun, J. ‐., Bérard, E., du Rieu, M. C., Hanaire, H. P., & Ritz, P. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.10.073 · Cited by 7
Ding, L., Zhuo, C., Fan, Y., Zhang, Y., Li, H., Qi, D., Tang, S., Cui, J., He, Q., & Liu, M. R. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028430 · Cited by 7
Cevallos, L., Rodríguez, F. M., Herrera-González, A., Sepúlveda, E. M., Donatini, G., Guilbert, L., & Zerrweck, C. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05275-3 · Cited by 7
Turquetil, A., Morello, R., Joubert, M., Roux, Y. L., & Reznik, Y. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101255 · Cited by 8
Bariatric Surgery: Late Outcomes in Patients Who Reduced Comorbidities at Early Follow-Up
de Almeida, R. R., Aidar, F. J., de Souza, M. F. C., Oliveira, V. B., Oliveira, J. L. M., Baumworcel, L., Pereira, L. M. C., de Oliveira, L. M. S. M., Costa, J. O., Rocha, R. G., et al. (2021) · Medicina · doi:10.3390/medicina57090995 · Cited by 11
Soroceanu, R. P., Soroceanu, A., Timofte, D. V., Timofeiov, S., Tănase, A. E., Iordache, G. A., Ambrosie, L., Miler, A. A., & Azoicăi, D. (2023) · Chirurgia · doi:10.21614/chirurgia.2023.v.118.i.4.p.348 · Cited by 7
“The remission rate of type 2 diabetes varies depending on the chosen type of surgical procedure, the duration of the illness, and the criteria used to define remission (49,51-56).”
Chaiyasoot, K., Sakai, N. S., Zakeri, R., Makaronidis, J., Crisóstomo, L., Alves, M. G., Gan, W., Firman, C., Jassil, F. C., Hall-Craggs, M. A., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06905-8 · Cited by 8
“…remission was normal HbA 1c levels ( 5.7% [39 mmol/mol]) and fasting plasma glucose (FPG) 5.6 mmol/l for ≥ 1 year without active pharmaco-therapy and partial remission was HbA 1C levels at 5.7 – 6.4% (39–46 mmol/mol) and FPG at 5.6–6.9 mmol/l for ≥ 1 year without active pharmacotherapy [7].”
BackgroundInfluentialResolution of Diabetes After Bariatric Surgery Among Predominantly African-American Patients
Araia, M., Wood, M., Kroll, J. J., Abou‐Samra, A., & Seyoum, B. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1187-0 · Cited by 8
Use of bariatric surgery in patients with type 2 diabetes: help to the practitioner
Ershova, E. V., & Troshina, E. A. (2016) · Obesity and metabolism · doi:10.14341/omet2016150-56 · Cited by 12
Chowbey, P. K., Kelkar, R., Soni, V., Khullar, R., Sharma, A., & Baijal, M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05129-4 · Cited by 7
Chaturvedi, R. R., Gračner, T., Tysinger, B., Narain, K. D. C., Goldman, D. P., & Sturm, R. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005517 · Cited by 8
Studer, A.-S., Magdy, M., Bacon, S., Denis, R., Pescarus, R., Garneau, P. Y., & Atlas, H. (2022) · Canadian Journal of Surgery · doi:10.1503/cjs.021820 · Cited by 7
Chuah, L. L., & le Roux, C. W. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6709 · Cited by 8
“6 mmol/L) for at least one year after bariatric surgery without glucose lowering medi cation.(13) Pournaras et al.”
BackgroundGuilbert, L., Joo, P., Ortiz, C., Sepúlveda, E. M., Alabi, F., León, A. D. B. D., Piña, T., & Zerrweck, C. (2018) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2018.05.002 · Cited by 13
Ferraz, Á. A. B., de Sá, V. C. T., Santa‐Cruz, F., Siqueira, L. T., Silva, L. B., & Campos, J. M. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.02.006 · Cited by 8
Frimpong, E., & Nlooto, M. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.34.93.19112 · Cited by 8
Kruschitz, R., Wakolbinger, M., Schindler, K., Prager, G., Hoppichler, F., Marculescu, R., & Ludvik, B. H. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.08.011 · Cited by 7
Efficacy in type 2 diabetes mellitus remission in patients undergoing bariatric surgery
Castro, F. M. P.-G., García, J. G. O., Núñez, M. A. G., Bray, B. F. G., Llanos, J. P. S., Arce, M. E. M., & Abizanda, J. E. P. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.08.003 · Cited by 9
The Potential Mechanism of Remission in Type 2 Diabetes Mellitus After Vertical Sleeve Gastrectomy
Wang, R., Mijiti, S., Xu, Q., Liu, Y., Deng, C., Huang, J., Yasheng, A., Tian, Y., Cao, Y., & Su, Y. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07378-z · Cited by 9
“Some clinical studies have suggested that the complete remission rate of DM is approximately 60–61% at 2–10 years follow-up after VSG [17–21].”
Analysis of the Efficacy of Different Obesity Surgeries in Patients with Metabolic Syndrome
Qi, T., Ding, Y., Dai, X., He, J., Zhang, H., & Wu, L. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07673-3 · Cited by 6
“The diabetes remission rate followed American Diabetes Association (ADA) standards [13].”
Wu, X., Huang, Q., Ding, Y., Cao, Q., Jiang, Y., Xu, Y., Zhao, Z., Xu, M., Lu, J., Wang, T., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16180 · Cited by 7
O efeito em curto prazo do bypass gástrico sobre pacientes obesos diabéticos
Stoll, A., Silva, J. C., Bahten, L. C. V., Gugelmin, G., Vedan, A. B., & de Souza, B. V. (2013) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/s0100-69912013000100003 · Cited by 9
Guerreiro, V. A., Maia, I., Neves, J. S., Salazar, D. A., Ferreira, M. J., Mendonça, F. M., Silva, M. M., Viana, S., Costa, C. F., Pedro, J. M. P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00584-0 · Cited by 7
Goals of cure: Perspectives on the concept of cure in type 2 diabetes
Zhao, D. X. (2022) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13666 · Cited by 6
“In 2009, a group of endocrinology, diabetes education, transplantation, metabolism, bariatric/metabolic surgery and haematology‐oncology professionals came together to discuss the differences between management, remission and cure inT2D, and whether it is accurate to describe any chronic condition as curable.(3) While…”
BackgroundLing, J., Tang, H., Meng, H., Wu, L., Zhu, L., & Zhu, S. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01811-9 · Cited by 6
Remission of corneal and peripheral neuropathy after bariatric surgery in people with diabetes
Misra, S. L., Slater, J. A., Makam, R., Braatvedt, G. D., Beban, G. R., Pradhan, M. A., Mankowski, J. L., Oakley, J. D., & McGhee, C. N. J. (2024) · The Ocular Surface · doi:10.1016/j.jtos.2024.07.006 · Cited by 6
Bariatric versus diabetes surgery after five years of follow up
Lee, W., Almulaifi, A. M., Chong, K., Yao, W.-C., Tsou, J. J., Ser, K., Lee, Y.-C., Chen, S., & Chen, J. (2015) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2015.04.001 · Cited by 7
“5%).(23) Patients were also asked to grade their satisfaction with the surgery at the annual visits.”
BackgroundVella, A. V. (2013) · Diabetes · doi:10.2337/db13-0806 · Cited by 8
“Indeed, various procedures have been associated with high rates of diabetes remission (1), although the outcomes of these studies have been assessed in a heterogeneous manner (2).”
BackgroundPros and cons of Roux en-Y gastric bypass surgery in obese patients with type 2 diabetes
Justinussen, T., Madsbad, S., Holst, J. J., & Bojsen-Møller, K. N. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1628639 · Cited by 7
Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve Gastrectomy
Al‐Ozairi, E., Samad, A. E., Kandari, J. A., Taghadom, E., Adam, S., le Roux, C. W., & Syed, A. A. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04505-4 · Cited by 6
El-Sayes, I., Abdelbaki, T. N., Elkeleny, M. R., & Sharaan, M. A. (2020) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2020.0432 · Cited by 6
Single-Anastomosis Duodenal Switch: Conceptual Difference between East and West
Li, C., Lin, S., & Liang, H. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05441-7 · Cited by 6
Park, J. Y., Kwon, O. K., Jeon, J., Choi, Y., & Park, K. B. (2021) · Scientific Reports · doi:10.1038/s41598-021-02001-y · Cited by 8
Teshome, T., Sorato, M. M., Ayele, A., Hailu, T., Tunje, A., & Bussa, Z. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.355 · Cited by 7
Dietary management of adults with type 2 diabetes and the role of the nurse
Boocock, R. C. (2023) · Nursing Standard · doi:10.7748/ns.2023.e11960 · Cited by 7
Phan, F., Oppert, J., & Andréelli, F. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70903-4 · Cited by 6
Güner, A., Cho, G. S., Son, T., Kim, H., Noh, S. H., & Hyung, W. J. (2017) · Oncotarget · doi:10.18632/oncotarget.22262 · Cited by 7
Gastric liposarcoma in a patient with severe obesity
Girardot-Miglierina, A., Clerc, D., & Suter, M. (2018) · Annals of The Royal College of Surgeons of England · doi:10.1308/rcsann.2018.0018 · Cited by 6
Consenso ALAD. Tratamiento del paciente con diabetes mellitus tipo 2 y obesidad
BRAJKOVICH, I. E., Aschner, P. J., Taboada, L. B., Camperos, P., Gómez‐Pérez, R., Aure, G., Velásquez, M. E., Halpern, B., Jiménez, M. C. H., & Fuentes, O. (2019) · Alad · doi:10.24875/alad.19000369 · Cited by 11
Mazzini, G. S., Khoraki, J., Browning, M. G., Pessoa, B. M., Wolfe, L. G., & Campos, G. M. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04247-y · Cited by 6
“5% in the absence of T2D medication use [12, 13].”
BackgroundBariatric surgery‐induced weight loss in patients with and without type 2 diabetes mellitus
CARVALHO, T. A., Ronsoni, M. F., Hohl, A., & van de Sande‐Lee, S. (2020) · Clinical Obesity · doi:10.1111/cob.12356 · Cited by 7
Sugiyama, S., Jinnouchi, H., Hieshima, K., Kurinami, N., & Jinnouchi, K. (2020) · Cureus · doi:10.7759/cureus.7110 · Cited by 6
Machado, N. M., Cardinelli, C. D. S., Shen, T., Santo, M. A., Torrinhas, R. S., & Waitzberg, D. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-66688-1 · Cited by 6
Sleeve gastrectomy in class 1 obesity: Assessment of operative outcomes
Şen, O., Çalıkoğlu, İ., Özgen, G., Türkçapar, A. G., & Yerdel, M. A. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.08.014 · Cited by 6
Sawada, S., Kodama, S., Tsuchiya, S., Kurosawa, S., Endo, A., Sugawara, H., Hosaka, S., Kawana, Y., Asai, Y., Yamamoto, J., et al. (2020) · Clinical Obesity · doi:10.1111/cob.12409 · Cited by 6
da Silva, J. G., Silva, C. S., Alexandre, B., & Morgado, P. F. (2020) · Portuguese Journal of Public Health · doi:10.1159/000511216 · Cited by 10
Akkuş, G., & Tetıker, T. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i8.1312 · Cited by 6
Cardelo, M. P., Alcala-Diaz, J. F., Gutierrez-Mariscal, F. M., López-Moreno, J., Villasanta‐Gonzalez, A., Larriva, A. P. A.-D., de la Cruz, S., Delgado‐Lista, J., Rodríguez-Cantalejo, F., Luque, R. M., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100652 · Cited by 6
β-Cell Function After Weight-Loss Induced by Bariatric Surgery
Vella, A. V. (2014) · Physiology · doi:10.1152/physiol.00003.2014 · Cited by 7
Bekken, T., Ottesen, N., Glenton, C., & Nordheim, L. V. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332276 · Cited by 5
Moral challenges with surgical treatment of type 2 diabetes
Hofmann, B., Hjelmesaeth, J. S., & Søvik, T. T. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.07.006 · Cited by 6
“The definition of remission of T2DM, for example, has important implications for the effect size (Buse et al., 2009; Pournaras et al., 2012).”
BackgroundWei, J.-H., Lee, M.-H., Lee, W., Chen, S., Almalki, O. M., Chen, J., Wu, C., & Lee, Y.-C. (2022) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2021.12.064 · Cited by 6
Ojeda‐Rodríguez, A., Alcala-Diaz, J. F., Rangel-Zúñiga, O. A., Larriva, A. P. A.-D., Gutierrez-Mariscal, F. M., Torres-Peña, J. D., Mora-Ortiz, M., Romero‐Cabrera, J. L., Luque, R. M., Ordovás, J. M., et al. (2024) · Antioxidants · doi:10.3390/antiox13010125 · Cited by 6
“…required the following criteria: (i) levels of HbA1c 6.5% (48 mmol/mol), (ii) fasting plasma glucose 126 mg/dL, and (iii) a 2 h plasma glucose value after 75 g in the OGTT 200 mg dL − 1 without the use of diabetes medication to lower blood glucose levels maintained for at least 2 years [21].”
BackgroundInfluentialLiu, Z., Huang, Z., Zhang, Y., Gao, L., Yang, Y., Chen, X., Zhao, W., Ma, L., Wang, Y., Dong, Z., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07105-8 · Cited by 6
“The remission criteria for T2DM in this study were < 6.5 HBA1c without any medication for 1 year, which included complete and partial remission of T2DM as described by Buse et al. Weight loss was measured by EWL% [13].”
InfluentialRemission of type 2 diabetes mellitus: Emerging concepts and proposed diagnostic criteria
Raveendran, A. V. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i4.95210 · Cited by 5
Seven Years Follow-Up after Sleeve Gastrectomy in Adolescents
Shehata, M. A., Abosena, W., Elhaddad, A., & Attar, A. E. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07966-7 · Cited by 5
“Complete remission of T2DM was defined as the maintenance of normalized glucose metabolism (characterized by normal HbA1c levels and a fasting glucose level below 100 mg/dL) for a minimum of one year without the use of any pharmacological agents [15].”
A 5-year assessment of the epidemiology and natural history of possible diabetes in remission
Gillani, S. M. R., Raghavan, R., & Singh, B. M. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.04.007 · Cited by 5
Cui, B., Li, W., Wang, G., Li, P., Zhu, L., & Zhu, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1068917 · Cited by 7
“Briefly, we followed a fourstep process to identify potential predictors and the optimal predictive model: (1) variable reduction: univariate logistic regression analysis was performed to reduce the redundant variables and filter out those with weak predictive power; (2) variable transformation: the receiver operating…”
BackgroundMethodResultInfluentialPreventing Type 2 Diabetes, CVD, and Mortality: Surgical Versus Non-surgical Weight Loss Strategies
Pournaras, D. J., & le Roux, C. W. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0367-z · Cited by 5
On Behalf of the LAGB10 Group, Pontiroli, A. E., Zakaria, A. S., Micheletto, G., Osio, C., Saibene, A., & Folli, F. B. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1221-0 · Cited by 5
Effect of gastric bypass on BMI and lipid metabolism in type 2 diabetes mellitus
Zhang, C., Cai, W., Zhao, H., Zhu, M. J., Cui, J., & Sun, Z. (2020) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2020.1770263 · Cited by 5
Kheniser, K. G., Aminian, A., & Kashyap, S. R. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01350-8 · Cited by 5
Haran, C., Lim, Y. K., Aljanabi, I., Bann, S. D., & Wickremesekera, S. K. (2022) · Medicine · doi:10.1097/md.0000000000029687 · Cited by 5
Kunešová, M., Sedláčková, B., Bradnová, O., TVRZICKÁ, E., Staňková, B., Šrámková, P., Dolezalova, K., Kalousková, P., Hlavatý, P., Hill, M., et al. (2015) · Physiological Research · doi:10.33549/physiolres.933132 · Cited by 7
“Diabetes remission was estimated according to Buse et al. (2009).”
Does the encounter type matter when defining diabetes complications in electronic health records?
Hong, D., Shen, Y., Monnette, A., Liu, S., Shao, H., Nauman, E., Price-Haywood, E., Hu, G., & Shi, L. (2020) · Medical Care · doi:10.1097/mlr.0000000000001297 · Cited by 4
Baldane, S., Çelik, M., Körez, M. K., Yılmaz, H., Abuşoğlu, S., Kebapçılar, L., & Alptekin, H. (2024) · Journal of Minimal Access Surgery · doi:10.4103/jmas.jmas_321_23 · Cited by 4
“[12] All data collection and analyses were executed in compliance with the ethical standards outlined in the Declaration of Helsinki.”
Gul, D., Khan, A. W., Butt, M. A., Suheb, M. K., Sartaj, S., Chabria, S., Bint-e-Hina, R., Shaukat, M., Ali, Z., Bhurchandi, S. K., et al. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01526-z · Cited by 4
“Bariatric Surgery has demonstrated greater efficacy in achieving T2DM remission in patients in which other non-surgical therapies have failed [6].”
Kratuloek, K., Kumam, P., Nikam, V., Gopal, D., & Seangwattana, T. (2025) · Mathematical and Computer Modelling of Dynamical Systems · doi:10.1080/13873954.2025.2488182 · Cited by 5
“As reported in the paper (Buse et al. 2009), the term ‘remission’ is often more suitable than ‘cure’ for long-term diseases like diabetes, HIV and cancer.”
Recent progress of remission in type 2 diabetes
Zhao, Z., Yue, H., Zhang, X., Chen, F., Xu, J., & Shao, S. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251408210 · Cited by 4
Ramírez-Avilés, E., Espinosa, O., Amado-Galván, M., Maydón, H., Sepúlveda-Guerrero, E., & Zerrweck, C. (2016) · Cirugía y Cirujanos · doi:10.1016/j.circir.2016.07.005 · Cited by 5
Liu, Y., Gang, X., Gao, Y., Wang, Y., & Wang, G. (2025) · Medicine · doi:10.1097/md.0000000000042257 · Cited by 5
“[29] In 2019, the Association of British Clinical Diabetologists/Primary Care Diabetes Society stated in regards to type 2 diabetes remission that in order to alleviate type 2 diabetes, the clinical pathway is changing to provide support and appropriate follow-up.”
The advent of bariatric surgery for diabetes in India
Varghese, R. T. (2013) · BMJ · doi:10.1136/bmj.f3391 · Cited by 4
Whyte, M., Johnson, R., Cooke, D., Hart, K. H., McCormack, M., & Shawe, J. (2016) · British Journal of Midwifery · doi:10.12968/bjom.2016.24.6.434 · Cited by 4
Estimating Disease Onset Time by Modeling Lab Result Trajectories via Bayes Networks
Oh, W., Yadav, P., Kumar, V., Caraballo, P. J., Castro, M. R., Steinbach, M. S., & Simon, G. (2017) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi.2017.41 · Cited by 4
Vennapusa, A., Panchangam, R. B., Kesara, C., & Madivada, M. S. S. (2020) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2020.9.2.33 · Cited by 4
Diabetes remission after malabsorptive bariatric surgery
Arnáiz, E. G., Ballesteros-Pomar, M. D., de la Maza, B. P., Roza, L. G., Bachiller, B. R., Galindo, D. E. B., Fondo, A. U., Cobo, D. A., Moreno, A. H., González-Herráez, L., et al. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.08.014 · Cited by 4
Moh, M. C., Cheng, A. K. S., Tan, C. H., Low, S. K., Tan, B. C., Ng, D., Subramaniam, T., Sum, C. F., & Lim, S. C. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06342-z · Cited by 4
“5% and cessation of glucose-lowering medications at 12 months after surgery [15, 16].”
BackgroundMid-Long-Term Effect of Metabolic Surgery on Type 2 Diabetes in Nonobese Patients: a Meta-analysis
Zou, X., Liu, Z., Huang, Z., Huang, J., Wang, X., Chen, Y., Yang, J., & Guan, B. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06713-0 · Cited by 4
Kim, E. R., Yun, J. H., Kim, H.-J., Park, H. Y., Heo, Y., Park, Y. S., Park, D. J., & Koo, S. K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1171675 · Cited by 4
Chirurgie métabolique du diabète de type 2
Amouyal, C., & Andréelli, F. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30200-5 · Cited by 5
Moanţă, M. L., Moța, M., Copăescu, C., & Dumitrache, C. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0042-0 · Cited by 4
“According to the recommendations from an expert consensus meeting organized in 2009 by the American Diabetes Association [26] and in agreement to the new (2011) American Diabetes Association cut points for T2DM and IGT diagnosis [27], complete remission of T2DM was defined as a FPG level of less than 100 mg/dl and HbA…”
MethodInfluentialIntegrating medical and surgical therapies to optimize the outcomes of type 2 diabetes
Ceccarini, G., Ciccarone, A. M., Santini, F., & Prato, S. D. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.01.035 · Cited by 4
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.